Oxytocin nasal spray ( DrugBank: Oxytocin )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
72	下垂体性ADH分泌異常症	1
193	プラダー・ウィリ症候群	1

72. 下垂体性ADH分泌異常症

臨床試験数 : 41 / 薬物数 : 27 - (DrugBank : 8) / 標的遺伝子数 : 7 - 標的パスウェイ数 : 10

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04789148 (ClinicalTrials.gov)	June 2023	5/3/2021	Effects of Intranasal Oxytocin in Patients With Central Diabetes Insipidus	Effects of Intranasal Oxytocin in Patients With Central Diabetes Insipidus - A Pilot Study	Central Diabetes Insipidus	Drug: Oxytocin nasal spray	Elizabeth Austen Lawson	NULL	Not yet recruiting	18 Years	60 Years	All	30	Phase 1	United States

臨床試験数 : 113 / 薬物数 : 111 - (DrugBank : 26) / 標的遺伝子数 : 48 - 標的パスウェイ数 : 102

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05298085 (ClinicalTrials.gov)	April 5, 2022	17/3/2022	Effect of Intranasal Oxytocin on Dysphagia in Children and Adolescents With Prader-Willi Syndrome	Effect of Intranasal Oxytocin on Dysphagia Related to Oropharyngo-oesophageal Dysmotility in Childre ...	Prader-Willi Syndrome	Drug: Oxytocin nasal spray;Drug: Placebo	University Hospital, Toulouse	NULL	Active, not recruiting	2 Years	17 Years	All	25	Phase 2/Phase 3	France